Results showed that after being preincubated with 10 μg/ml gp120JRFLD368R, all CNsera find more lost their reactivity with gp120JRFLD368R (Fig. 2B),

suggesting that the gp120-reactive non-CD4bs antibodies in CNsera were completely adsorbed. None of the CNsera except Serum 13 could reactive with gp120JRFL after adsorbed by 10 μg/ml gp120JRFLD368R (Fig. 2B), indicating that only Serum 13 contained CD4bs-specific antibody. Antibodies to glycans are rare, but a number of glycan-specific mAbs have been isolated from HIV-1-infected individuals and shown to exhibit broadly neutralizing activities. 2G12 is one of the most broadly neutralizing mAbs that recognize the glycan moiety on gp120. We investigated whether 2G12-like antibodies were present NVP-AUY922 molecular weight in the sera by analysing their reactivity with gp120IIIB in the presence of D-mannose and showed that the CNsera binding to gp120IIIB was reduced by 15–55% when D-mannose reached 2M (Fig. 3A). As a control, the reactivity of 2G12 to gp120IIIB was completely inhibited by 2M D-mannose, while the reactivities of non-glycan-dependent mAbs (b12, 447-52D) were not affected at all (Fig. 3B), consistent with earlier studies on serum antibodies [31]. Therefore, we conclude that mannose glycan-dependent antibodies widely existed in all eight CNsera. Kifunensine is a mannosidase

inhibitor that Edoxaban blocks Man9GlcNAc2 trimming to Man5GlcNAc2. HIV-1 pseudovirus generated in the presence of kifunensine will carry high mannose glycans [32] and become insensitive to PG9 and PG16 neutralization and more sensitive to 2G12 neutralization [33]. Three pseudoviral isolates (CNE6kifu, CNE55kifu and JRFLkifu) produced in the presence of kifunensine were analysed for their sensitivities to CNsera neutralization. CNE6kifu and CNE55kifu became completely resistant to PG9 neutralization (Fig. 4A), consistent with previous study [33].

Therefore, we used CNE6kifu and CNE55kifu to screen for the PG9-like antibodies in the CNsera. CNE6kifu and JRFLkifu showed higher neutralization sensitivity to 2G12 than CNE6 and JRFL (Fig. 4B). Therefore, CNE6kifu and JRFLkifu were used for probing 2G12-like antibodies in the CNsera. In eight CNsera, only Serum 45 potently neutralized both CNE6 and CNE55, but completely failed to neutralize CNE6kifu and neutralized CNE55kifu with significantly reduced potency (Fig. 5A), suggesting that PG9-like antibodies were present in Serum 45 and contributed a major neutralization activity against these two isolates. N-linked glycosylation at 160 site on virus Env is critical for PG9 recognition and neutralization [11, 33], so we generated an N160K mutant from parental viruses CNE6 and CNE55 and the mutant pseudoviruses CNE6N160K and CNE55N160K were completely resistant to PG9 neutralization (Fig. 4A).